Concepedia

Advanced Glycation End-Products, Anti-Hypertensive Treatment and Diastolic Function in Patients with Hypertension and Diastolic Dysfunction

Jasper W.L. Hartog, Ruud M. van de Wal, Casper G. Schalkwijk, Toshio Miyata, Wybren Jaarsma, H.W. Thijs Plokker, Leen M. van Wijk, Andries J. Smit, Dirk J. van Veldhuisen, Adriaan A. Voors

European Journal of Heart Failure · 2010 · 24 citations · 16 references

DOIFull text

Open access

Abstract

Although eprosartan did not decrease levels of AGEs, patients with lower skin-AF at baseline showed a larger improvement in diastolic function in response to either anti-hypertensive treatment compared with patients with higher skin-AF.

References

16

Simple non-invasive assessment of advanced glycation endproduct accumulation

Robbert Meerwaldt, R. Graaff, P. H. N. Oomen et al. · Diabetologia · 2004 · 742 citations · Full text

, , +8

Diastolic Stiffness of the Failing Diabetic Heart

Loek van Heerebeek, Nazha Hamdani, M. Louis Handoko et al. · Circulation · 2007 · 721 citations · Full text

Skin Autofluorescence, a Measure of Cumulative Metabolic Stress and Advanced Glycation End Products, Predicts Mortality in Hemodialysis Patients

Robbert Meerwaldt, Jasper W.L. Hartog, Reindert Graaff et al. · Journal of the American Society of Nephrology · 2005 · 410 citations

, , +20

Drawbacks and Prognostic Value of Formulas Estimating Renal Function in Patients With Chronic Heart Failure and Systolic Dysfunction

Tom D.J. Smilde, Dirk J. van Veldhuisen, Gerjan Navis et al. · Circulation · 2006 · 296 citations · Full text

The Effect of Alagebrium Chloride (ALT-711), a Novel Glucose Cross-Link Breaker, in the Treatment of Elderly Patients With Diastolic Heart Failure

William C. Little, Michael R. Zile, Dalane W. Kitzman et al. · Journal of Cardiac Failure · 2005 · 293 citations

, , +12